Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CDKN3 Antibody (OTI2E11), Alexa Fluor™ 594, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP270399AF594

Catalog No. NP270399A94


Only null left
Add to Cart

Description

Description

CDKN3 Monoclonal specifically detects CDKN3 in Human, Mouse samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
Specifications

Specifications

CDKN3
Monoclonal
Alexa Fluor 594
50 mM sodium borate with 0.05% sodium azide
CDKN3
Full length recombinant protein of human CDKN3 (NP_005183) produced in HEK293T cells.
Primary
Human, Mouse
IgG1
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI2E11
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
CDI1KAP1, CDK2-associated dual specificity phosphatase, CDK2-associated dual-specificity phosphatase, Cdk-associated protein phosphatase, CIP2, cyclin-dependent kinase inhibitor 3, cyclin-dependent kinase interacting protein 2, Cyclin-dependent kinase interactor 1, Cyclin-dependent kinase-interacting protein 2, EC 3.1.3.16, EC 3.1.3.48, FLJ25787, KAPMGC70625, Kinase-associated phosphatase
Mouse
0.1 mL
1033
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.